CelluTarget · Multifocal Motor Neuropathy · Clinical Trials
Phase 1
Recruiting
NCT07610564

Empasiprubart (ARGX-117)

Sponsored by argenx ↗
View on ClinicalTrials.gov ↗
Timeline
Study Dates
Start Date
June 2026
Est. Completion
—
Enrollment Target
—
Status
Recruiting
Study Design
Primary Endpoint
Effect of empasiprubart on nerve morphology by ultrasound
Registry
ClinicalTrials.gov Record
Registry ID
NCT07610564
Direct Link
clinicaltrials.gov/NCT07610564 ↗
Related Treatment
Treatment Being Studied
Empasiprubart (ARGX-117) →